Senseonics Holdings, Inc. (SENS)
NYSEAMERICAN: SENS · Real-Time Price · USD
0.7371
+0.0441 (6.36%)
At close: Apr 23, 2025, 4:00 PM
0.7300
-0.0071 (-0.96%)
Pre-market: Apr 24, 2025, 4:09 AM EDT
Senseonics Holdings Revenue
In the year 2024, Senseonics Holdings had annual revenue of $22.47M with 0.37% growth. Senseonics Holdings had revenue of $8.30M in the quarter ending December 31, 2024, with 3.33% growth.
Revenue (ttm)
$22.47M
Revenue Growth
+0.37%
P/S Ratio
20.66
Revenue / Employee
$192,068
Employees
117
Market Cap
480.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22.47M | 82.00K | 0.37% |
| Dec 31, 2023 | 22.39M | 6.00M | 36.62% |
| Dec 31, 2022 | 16.39M | 2.71M | 19.85% |
| Dec 31, 2021 | 13.68M | 8.73M | 176.32% |
| Dec 31, 2020 | 4.95M | -16.35M | -76.77% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
SENS News
- 7 weeks ago - Senseonics Holdings, Inc. (SENS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - Eversense 365 and SweetSpot Integrate Software to Optimize Diabetes Care - GlobeNewsWire
- 2 months ago - Senseonics Holdings, Inc. to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - Senseonics Completes CE Mark Submission for Eversense 365, World's Longest-lasting Continuous Glucose Monitor - GlobeNewsWire
- 3 months ago - Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting - GlobeNewsWire
- 5 months ago - Senseonics Holdings, Inc. (SENS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System - GlobeNewsWire